Alternative Data for Henry Schein
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 293 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 660,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 170 | Sign up | Sign up | Sign up |
| Facebook Followers | 24,499 | Sign up | Sign up | Sign up |
| Instagram Followers | 21,178 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 955 | Sign up | Sign up | Sign up |
| X Followers | 25,067 | Sign up | Sign up | Sign up |
| X Mentions | 2 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,670 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 69 | Sign up | Sign up | Sign up |
| Linkedin Employees | 10,335 | Sign up | Sign up | Sign up |
About Henry Schein
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services.
| Price | $78.19 |
| Target Price | Sign up |
| Volume | 1,480,000 |
| Market Cap | $9.48B |
| Year Range | $62.03 - $81.69 |
| Dividend Yield | 0% |
| PE Ratio | 24.67 |
| Analyst Rating | 45% buy |
| Earnings Date | February 24 '26 |
| Industry | Health Care Services |
In the news
 |
Assessing Henry Schein (HSIC) Valuation As Growth And Returns Face Competitive PressureFebruary 8 - Yahoo |
|
Henry Schein Leadership Exit Tests Distribution Strength And Competitive PositionFebruary 8 - Yahoo |
|
What Henry Schein (HSIC)'s Activist-Backed Governance Shift and CEO Transition Means For ShareholdersJanuary 31 - Yahoo |
|
Greenlight Capital Backs Henry Schein As Governance Shifts Target MarginsJanuary 31 - Yahoo |
|
Does Henry Schein (HSIC) Have Potential for Margin Improvement and Increased Shareholder Value?January 29 - Yahoo |
|
Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ETJanuary 21 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 3.34B | 2.38B | 958M | 101M | 252M | 1.380 |
| Q2 '25 | 3.24B | 2.29B | 952M | 86M | 235M | 1.100 |
| Q1 '25 | 3.17B | 2.23B | 938M | 110M | 253M | 1.150 |
| Q4 '24 | 3.19B | 2.26B | 930M | 94M | 237M | 1.190 |
| Q3 '24 | 3.17B | 2.18B | 993M | 99M | 236M | 1.220 |
Insider Transactions View All
| DANIEL WILLIAM K filed to buy 10,000 shares at $67.1. August 11 '25 |
| Connett Bradford C filed to sell 62,688 shares at $71.2. March 20 '25 |
| LASKAWY PHILIP A filed to sell 24,805 shares at $71. March 20 '25 |
| KUEHN KURT P filed to sell 15,687 shares at $71.5. March 6 '25 |
| Ettinger Michael S filed to sell 87,706 shares at $75. November 20 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Abbott LaboratoriesABT |
$112.68 0% | 49 |
 |
HCA HealthcareHCA |
$540.29 0% | 45 |
 |
Cardinal HealthCAH |
$220.79 0% | 43 |
 |
Idexx LaboratoriesIDXX |
$629.35 0% | 66 |
 |
LabCorpLH |
$282.63 0% | 63 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Michael McCaul |
Feb 12, 26 | Sell | $15K - $50K |
| Julie Johnson |
May 15, 25 | Sell | $1K - $15K |
| Rob Bresnahan |
May 8, 25 | Buy | $1K - $15K |
Read more about Henry Schein (HSIC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Henry Schein
The Market Cap of Henry Schein is $9.48B.
As of today, Henry Schein's PE (Price to Earnings) ratio is 24.67.
Henry Schein will report its next earnings on February 24 '26.
Currently, the price of one share of Henry Schein stock is $78.19.
The HSIC stock price chart above provides a comprehensive visual representation of Henry Schein's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Henry Schein shares. Our platform offers an up-to-date HSIC stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Henry Schein (HSIC) does not offer dividends to its shareholders. Investors interested in Henry Schein should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Henry Schein are Abbott Laboratories, HCA Healthcare, Cardinal Health, Idexx Laboratories, and LabCorp.
